Let's catch up on the latest news from the stock market. From significant investments to major deals, quarterly earnings, order wins, and appointments, here’s a quick look at which stocks will be in focus in today's trade:

Results Today

Adani Power, Indus Towers, Indian Oil Corporation, Ajanta Pharma, Bandhan Bank, Coromandel International, CRISIL, Equitas Small Finance Bank, Exide Industries, Federal Bank, Godrej Agrovet, Greaves Cotton, Orient Green Power Company, Jindal Steel & Power, JSW Infrastructure, KSB, Paras Defence and Space Technologies, Phoenix Mills, Skipper, Sona BLW Precision Forgings, Sundram Fasteners, Ujjivan Small Finance Bank, Varun Beverages, and Vedanta will release quarterly earnings on April 30.

Results on May 1

Adani Enterprises, Adani Ports and Special Economic Zone, Eternal (Zomato), 5paisa Capital, Bondada Engineering, Home First Finance Company India, Jaiprakash Power Ventures Nuvoco Vistas Corporation, RailTel Corporation of India, and SIS will announce their March 2025 quarter earnings on May 1.

Quarterly Earnings

Bajaj Finance Q4 (Consolidated YoY)

Profit grows 19% to Rs 4,546 crore Vs Rs 3,825 crore

Net interest income soars 22% to Rs 9,807 crore Vs Rs 8,013 crore

Assets under management (AUM) grows 26% to Rs 4,16,661 crore Vs Rs 3,30,615 crore as of 31March2024. AUM grew by z 18,618 crore in 04 FY25.

Board announces bonus equity shares in 4:1 ratio, stock split in 2:1 ratio

Board recommends final dividend of Rs 44 per share, special dividend of Rs 12 per share

Bajaj Finserv Q4 (Consolidated YoY)

Profit jumps 14.1% to Rs 2,416.6 crore Vs Rs 2,118.5 crore

Revenue increases 14.2% to Rs 36,595.4 crore Vs Rs 32,040.8 crore

Bharat Petroleum Corporation (BPCL) Q4 (Standalone QoQ)

Profit sinks 30.9% to Rs 3,214.1 crore Vs Rs 4,649.2 crore

Revenue declines 1.7% to Rs 1,11,179 crore Vs Rs 1,13,136 crore

Board recommends final dividend of Rs 5 per share

Jana Small Finance Bank Q4 (YoY)

Profit tanks 61.6% to Rs 123.5 crore Vs Rs 321.7 crore

Net interest income rises 0.9% to Rs 596.9 crore Vs Rs 591.8 crore

Tax credit at Rs 3.64 crore Vs tax credit at Rs 155.2 crore

Gross NPA falls to 2.71% Vs 2.80% (QoQ)

Net NPA flat at 0.94% (QoQ)

UTI Asset Management Company Q4 (Standalone YoY)

Profit drops 18% to Rs 124 crore Vs Rs 151.3 crore

Revenue declines 3.2% to Rs 316.9 crore Vs Rs 327.5 crore

Board recommends final dividend of Rs 26 per share, special dividend of Rs 22 per share

Star Health and Allied Insurance Company Q4 (YoY)

Profit plunges 99.6% to Rs 0.51 crore Vs Rs 142.3 crore

Net premium earned grows 11.9% to Rs 3,798.3 crore Vs Rs 3,395.3 crore

Underwriting loss widens to Rs 275.2 crore Vs loss of Rs 91.8 crore

Operating loss stands at Rs 86.9 crore Vs operating profit of Rs 90 core

Ceat Q4 (Consolidated YoY)

Profit falls 8.4% to Rs 99.5 crore Vs Rs 108.6 crore

Revenue increases 14.3% to Rs 3,420.6 crore Vs Rs 2,991.9 crore

Board recommends dividend of Rs 30 per share

Vishal Mega Mart Q4 (Consolidated YoY)

Profit zooms 88% to Rs 115.1 crore Vs Rs 61.2 crore

Revenue grows 23.2% to Rs 2,547.9 crore Vs Rs 2,068.9 crore

Shoppers Stop Q4 (Consolidated YoY)

Profit sinks 91.4% to Rs 1.99 crore Vs Rs 23.2 crore

Revenue grows 1.7% to Rs 1,064 crore Vs Rs 1,046.3 crore

Board appoints Nirvik Singh, Non-Executive Director, as Chairman of the company

BS Nagesh retires as Chairman and Non- Executive Director

CIE Automotive India Q4 (Consolidated YoY)

Profit drops 10.4% to Rs 206.4 crore Vs Rs 230.5 crore

Revenue falls 6.4% to Rs 2,272.6 crore Vs Rs 2,426.8 crore

Praj Industries Q4 (Consolidated YoY)

Profit sinks 56.7% to Rs 39.8 crore Vs Rs 91.9 crore

Revenue drops 15.6% to Rs 859.7 crore Vs Rs 1,018.6 crore

Schaeffler India Q1 (Consolidated YoY)

Profit grows 14.5% to Rs 251.6 crore Vs Rs 219.7 crore

Revenue jumps 16.1% to Rs 2,174.4 crore Vs Rs 1,873.1 crore

Indostar Capital Finance Q4 ((Standalone YoY)

Profit declines 36.5% to Rs 12.4 crore Vs Rs 19.6 crore

Net interest income drops 21.7% to Rs 179.2 crore Vs Rs 228.7 crore

Fedbank Financial Services Q4 (YoY)

Profit increases 5.9% to Rs 71.7 crore Vs Rs 67.7 crore

Net interest income soars 34.6% to Rs 283.3 crore Vs Rs 210.5 crore

IndiaMART InterMESH Q4 (Consolidated YoY)

Profit spikes 81.3% to Rs 180.6 crore Vs Rs 99.6 crore

Revenue grows 12.8% to Rs 355.1 crore Vs Rs 314.7 crore

Board recommends final dividend of Rs 30 per share, special dividend of Rs 20 per share

Stocks to Watch

Infosys

The digital services and consulting company announced the launch of Infosys Topaz for SAP S/4HANA Cloud, an AI-first suite. This offering will help enterprises harness the power of AI and Gen AI in their SAP S/4HANA Cloud transformation journey.

State Bank of India (SBI)

The Board will meet on May 3 to consider raising equity during FY26 through follow-on public offer (FPO), rights issue, qualified institutional placement (QIP), or any other mode. The Board will also consider the March quarter and FY25 earnings on the same day.

GlaxoSmithKline Pharmaceuticals

Shareholders have approved the re-appointment of Juby Chandy as the company's Full-Time Director and CFO for a period of two years, effective April 1.

MMTC

Nitin Kumar Yadav, IAS, Joint Secretary, Department of Commerce, has been appointed as Chairman & Managing Director (CMD) (additional charge) on the Board of the company for a period of one year, effective April 29.

V-Mart Retail

The Board will consider the issue of bonus shares on May 2.

Prestige Estates Projects

The company has received approval from the Real Estate Regulatory Authority (RERA) and has launched the residential project ‘The Prestige City – Indirapuram’ in the National Capital Region (NCR). The gross development value (GDV) of the project is estimated at over Rs 9,000 crore.

Strides Pharma Science

The company’s subsidiary, Strides Pharma Inc, in the US has acquired four approved ANDAs for the US market from Nostrum Laboratories Inc., USA. The portfolio comprises liquids and immediate-release solid orals in therapeutic segments that treat urinary tract infections (UTIs), pain management, allergy symptoms, attention deficit disorder (ADD/ADHD), and narcolepsy. The cumulative market size for the acquired portfolio is $57 million, as per IQVIA 2025 data.

Alembic Pharmaceuticals

The company has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (US FDA) for its Oncology (injectable and oral solid) formulation facility (F-2) at Panelav. The US FDA inspected on October 7–8, 2024.

IndusInd Bank

Sumant Kathpalia has resigned as Managing Director and CEO, effective April 29. The Board has sought approval from the Reserve Bank of India (RBI) to constitute a Committee of Executives to discharge the CEO's duties, roles, and responsibilities for an interim period until a permanent CEO is appointed. In his resignation letter, Kathpalia stated that he was stepping down about the ongoing derivatives discussion and undertook moral responsibility for various acts of commission/omission.

Bulk Deals

Tata Technologies

TPG Rise Climate SF Pte sold a 3.91% stake in the company at an average price of Rs 673.26 per share, amounting to Rs 1,068.04 crore.

Block Deals

Samhi Hotels

Blue Chandra Pte has exited the company by selling its entire 3.96% shareholding at an average price of Rs 174.3 per share, valued at Rs 152.01 crore. Buyers for the 3.96% stake at the same price included LGT Select Funds, BofA Securities Europe SA, CBJ as Trustee for SMBCTB Emerging Markets Impact MF, Citigroup, TT International, Steinberg India, and Tata Mutual Fund.

SME Listing on April 30

Tankup Engineers

Stocks Trade Ex-Dividend

Tanla Platforms

Vesuvius India

Stock Trades Ex-Date for Rights

Bannari Amman Spinning Mills

Stocks Trade Ex-Date for Resolution Plan -Suspension

Aanchal Ispat

KDJ Holidayscapes and Resorts

Stocks in F&O ban

RBL Bank